Skip to content

Incorporating CV Risk Assessment in AYA Visits

Incorporating Cardiovascular Risk Assessment Into Adolescent and Young Adult Visits to Improve Cardiovascular Health

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05384834
Enrollment
60
Registered
2022-05-20
Start date
2022-07-01
Completion date
2023-04-03
Last updated
2023-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases

Brief summary

The purpose of this study is to evaluate the web tool #HerHeart's usability and feasibility in adolescent and young adult women (AYA) and the opinion of their healthcare providers (HCP).

Detailed description

The objective of the proposed research is to increase young women's perceived susceptibility to CVD and provide a cue to action to adopt heart-healthy behaviors. The aim of the proposed study is to evaluate the usability and initial feasibility of #HerHeart. The investigators will recruit 30 AYA participants and will ask 10 HCPs to evaluate the usability and feasibility of the web tool. The study population will include female patients ages 13-21 years from the CHOA Adolescent Medicine Practice and Grady Teen Health Program. Part of our study population will be considered vulnerable (children under the age of 18 years). Subjects will be recruited via phone in advance of a clinical visit, from the waiting rooms of each clinic at the time of their appointment (in-person) or via Zoom at a time scheduled after their telehealth appointment (virtual). Written informed consent will be obtained for subjects 18 years and older. For subjects younger than 18 years, written parental permission (unless doing so would violate the adolescents' right to privacy, in which the Waiver of Parental Permission will be invoked) and written informed assent will be obtained. All consent procedures will take place in a private research room of each clinic (for in-person visits) or via Zoom videoconferencing (for virtual visits). Participants who agree to participate will attend a study visit at the Emory Children's Center Research Unit. Data for this study will be collected from participants via surveys/questionnaires, and semi-structured interviews that will be audio-recorded. Data collected will include demographic information, cardiovascular disease risk information, health metrics (BMI, blood pressure), cognitive data (perceived stress, quality of life), and participant feedback on a mobile app intervention. All subjects will receive a study identification number. Only the PI will have the codes linking the study identification numbers to subjects and these codes will be stored in a locked cabinet. All data will be collected in a private research room in the clinics (in-person visits) or in a password-protected Zoom videoconference (virtual). All study staff will complete biomedical or socio-behavioral training through the Collaborative IRB Training Initiative Program (CITI). Data will be stored on the Emory servers in password-protected files.

Interventions

BEHAVIORAL#HerHeart tool

An integrated application consisting of a lifestyle-based CVD risk assessment and companion behavioral intervention. It will be administered at baseline and 3 months follow-up.

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Emory University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
13 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

(AYAs): * Patient at CHOA Hughes Spalding Adolescent Medicine Practice or the Grady Health System Teen Program * Age 13-21 years * Self-identifying as non-Hispanic Black or White race (inclusive of Hispanic ethnicity) * Self-identifying as female * Visit type is annual wellness/health check, behavioral/mental health, or reproductive/gynecological health * Consistent access to a mobile device with internet capability

Exclusion criteria

(AYAs): * Cognitive impairment limiting ability to complete study procedure * Spoken and written language other than English * Diagnosis of hypertension, diabetes, or hyperlipidemia requiring medications, or atherosclerotic cardiovascular disease * Past or current diagnosis of a DSM-V eating disorder * Diagnosis of schizophrenia, bipolar disorder, or psychiatric hospitalization in the past 12 months * Pregnant at the time of the study. Inclusion Criteria (HCPs) to complete feasibility surveys: * Clinical team member (physician or nurse practitioner, nurse, social worker, psychologist, health educator, medical assistant, dietitian) at the CHOA Hughes Spalding Adolescent Medicine Practice or the Grady Health System Teen Program * Practicing at one of the study sites at least twice per month on average over the past year

Design outcomes

Primary

MeasureTime frameDescription
Physical ActivityBaseline, 3 months post-enrollmentPhysical activity will be measured in number of hours per week. Increase in physical activity associated with a better outcome.
Alcohol ConsumptionBaseline, 3 months post-enrollmentNumber of participants who consume alcohol will be collected. No alcohol consumption is associated with a better outcome.
Nicotine UseBaseline, 3 months post-enrollmentSelf-reported smoker status will be obtained and classified as: Never smoke, used to smoke, current smoker. Investigators will look at changes in smoking status where a decrease in use is associated with a better outcome.
Cereal FiberBaseline, 3 months post-enrollmentConsumption of cereal will be measured in g/day. An increase in cereal fiber is associated with a better outcome.
#HerHEART Risk Score in AYA From BaselineBaseline, 3 months post-enrollmentRisk is assessed based on answers surrounding the most critical diet and lifestyle factors that can influence a person's CVD risk. The factors include exercise, intake of fruits, vegetables, grains, nuts, sugary beverages and red/processed meats, and exercise. The Healthy Heart Score algorithm will be used to calculate the relative percent risk score of participants. Participants with a higher percent risk score have a higher risk for CVD based on their current reported habits. Those at low risk will have a risk score \<10%, moderate risk a risk score between 10 and 15%, and high risk a score above 15%.
Overall Composite of Diet ScoreBaseline, 3 months months post-enrollmentDiet score = (0.03626 × grams/d of cereal fiber + 0.18283 \[if fruits + vegetables ≥3 servings/d\] + 0.14522 \[if nuts 0.1-1 servings/d + 0.2444 \[if nuts \>1 servings/d\]- 0.14631 × servings/d of sugar-sweetened beverages - 0.15624 × servings/d of red and processed meats)\*10 A higher score implies better diet quality. An increase in diet score correlates with a better outcome.
Fruit and Vegetable IntakeBaseline, 3 months post- post-enrollmentIntake will be measured with number of servings per day. Increase in servings/day correlates with a better outcome.
Red and Processed Meats IntakeBaseline, 3 months post-enrollmentIntake will be measured with number of servings per day. A decrease in consumption is associated with a better outcome.
Sugar and Sweetened BeveragesBaseline, 3 months post-enrollmentIntake will be measured with number of servings per week. A decrease in consumption is associated with a better outcome.
Nut ConsumptionBaseline, 3 months post-interventionIntake will be measured with number of servings per week. An increase in intake is associated with a better outcome.

Secondary

MeasureTime frameDescription
Systolic Blood Pressure (BP) From BaselineBaseline, 3 month post-enrollmentAYA participants' systolic BP (SBP) will be measured during the clinic appointment when the participant is recruited. AYA participants will then be asked to return for a study visit 3 months post-intervention where their BP will be measured again. Change in SBP will be measured with a decrease in SBP being associated with a positive outcome and an increase in SBP being associated with a negative outcome.
Diastolic Blood Pressure (BP) From BaselineBaseline, 3 month post-enrollmentAYA participants' diastolic BP (DBP) will be measured during the clinic appointment when the participant is recruited. AYA participants will then be asked to return for a study visit 3 months post-intervention where their BP will be measured again. Change in DBP will be measured with a decrease in diastolic BP being associated with a positive outcome and an increase in BP being associated with a negative outcome.
BMI From BaselineBaseline, 3 month post-enrollmentAYA participant's BMI will be measured during the clinic appointment when participant is recruited. AYA participants will then be asked to return for a study visit 3 months post intervention where their BMI will be measured again. Change in BMI will be measured with a decrease in BMI being associated with a positive outcome and an increase in BMI being associated with a negative outcome.

Countries

United States

Participant flow

Recruitment details

Participants were enrolled from Children's Healthcare of Atlanta - Hughes Spalding Research Room in Atlanta, Georgia, USA. Participant enrollment began July 01, 2022, and all follow-up assessments were completed by April 03, 2023.

Pre-assignment details

The healthcare providers (HCPs) were instructed to complete a short anonymous survey without demographic information. Demographic information was not required to answer the survey. HCPs were not enrolled. They were not actually part of the clinical trial, per the NIH definition of a clinical trial.

Participants by arm

ArmCount
AYA Participants
AYA participants will complete a brief initial survey consisting of demographic information and the Visual Analog Scale (VAS) and the #HerHeart tool in clinic. AYA participants will the rate the usability of the #HerHeart tool using the Website Analysis and Measurement Inventory (WAMMI), the likelihood they would recommend the app to their friends, and the likelihood of behavior change. AYA participants will then be offered the opportunity to continue into the 3-month intervention phase. #HerHeart tool: An integrated application consisting of a lifestyle-based CVD risk assessment and companion behavioral intervention. It will be administered at baseline and 3 months follow-up.
60
Total60

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up43
Overall StudyWithdrawal by Subject5

Baseline characteristics

CharacteristicAYA Participants
Age, Categorical
<=18 years
44 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
16 Participants
Age, Continuous17 years
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
Race (NIH/OMB)
Asian
1 Participants
Race (NIH/OMB)
Black or African American
50 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
7 Participants
Race (NIH/OMB)
White
1 Participants
Region of Enrollment
United States
60 participants
Sex: Female, Male
Female
60 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 60
other
Total, other adverse events
0 / 60
serious
Total, serious adverse events
0 / 60

Outcome results

Primary

Alcohol Consumption

Number of participants who consume alcohol will be collected. No alcohol consumption is associated with a better outcome.

Time frame: Baseline, 3 months post-enrollment

Population: Includes all participants who completed the baseline questionnaires, and the three-month follow-up includes only those who completed the study activities at the specific time point. Even though twelve (12) participants completed all activities, data was lost on 2 individuals.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
AYA ParticipantsAlcohol ConsumptionBaseline0 Participants
AYA ParticipantsAlcohol Consumption3 months post-enrollment0 Participants
Primary

Cereal Fiber

Consumption of cereal will be measured in g/day. An increase in cereal fiber is associated with a better outcome.

Time frame: Baseline, 3 months post-enrollment

Population: Includes all participants who completed the baseline questionnaires, and the three-month follow-up includes only those who completed the study activities at the specific time point. Even though twelve (12) participants completed all activities, data was lost on 2 individuals.

ArmMeasureGroupValue (MEDIAN)
AYA ParticipantsCereal FiberBaseline0.30 g/day
AYA ParticipantsCereal FiberThree months post-enrollment0.30 g/day
Primary

Fruit and Vegetable Intake

Intake will be measured with number of servings per day. Increase in servings/day correlates with a better outcome.

Time frame: Baseline, 3 months post- post-enrollment

Population: Includes all participants who completed the baseline questionnaires, and the three-month follow-up includes only those who completed the study activities at the specific time point. Even though twelve (12) participants completed all activities, data was lost on 2 individuals.

ArmMeasureGroupValue (MEDIAN)
AYA ParticipantsFruit and Vegetable IntakeFruits at Baseline2.00 Number of Servings per day
AYA ParticipantsFruit and Vegetable IntakeFruits at 3 months post-enrollment1.5 Number of Servings per day
AYA ParticipantsFruit and Vegetable IntakeVegetables at Baseline1.00 Number of Servings per day
AYA ParticipantsFruit and Vegetable IntakeVegetables at 3 months post-enrollment2.00 Number of Servings per day
Primary

#HerHEART Risk Score in AYA From Baseline

Risk is assessed based on answers surrounding the most critical diet and lifestyle factors that can influence a person's CVD risk. The factors include exercise, intake of fruits, vegetables, grains, nuts, sugary beverages and red/processed meats, and exercise. The Healthy Heart Score algorithm will be used to calculate the relative percent risk score of participants. Participants with a higher percent risk score have a higher risk for CVD based on their current reported habits. Those at low risk will have a risk score \<10%, moderate risk a risk score between 10 and 15%, and high risk a score above 15%.

Time frame: Baseline, 3 months post-enrollment

Population: Includes all participants who completed the baseline questionnaires, and the three months follow-up includes only those who completed the study activities at the specific time point. Even though twelve (12) participants completed all activities, data was lost on 2 individuals. HCPs, n=5 from the same two clinical practices in Atlanta, Georgia were recruited by the research coordinator only to understand their perspectives about incorporating the HerHeart tool into clinical practice.

ArmMeasureGroupValue (MEDIAN)
AYA Participants#HerHEART Risk Score in AYA From BaselineBaseline0.10 Percentage Risk
AYA Participants#HerHEART Risk Score in AYA From BaselineThree (3) months post-enrollment0.08 Percentage Risk
Primary

Nicotine Use

Self-reported smoker status will be obtained and classified as: Never smoke, used to smoke, current smoker. Investigators will look at changes in smoking status where a decrease in use is associated with a better outcome.

Time frame: Baseline, 3 months post-enrollment

Population: Includes all participants who completed the baseline questionnaires, and the three-month follow-up includes only those who completed the study activities at the specific time point. Even though twelve (12) participants completed all activities, data was lost on 2 individuals.

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
AYA ParticipantsNicotine UseBaselineNever Smoke46 Participants
AYA ParticipantsNicotine UseBaselineUsed to Smoke4 Participants
AYA ParticipantsNicotine UseBaselineCurrent Smoker10 Participants
AYA ParticipantsNicotine UseThree months post-enrollmentNever Smoke9 Participants
AYA ParticipantsNicotine UseThree months post-enrollmentUsed to Smoke1 Participants
AYA ParticipantsNicotine UseThree months post-enrollmentCurrent Smoker0 Participants
Primary

Nut Consumption

Intake will be measured with number of servings per week. An increase in intake is associated with a better outcome.

Time frame: Baseline, 3 months post-intervention

Population: Includes all participants who completed the baseline questionnaires, and the three-month follow-up includes only those who completed the study activities at the specific time point. Even though twelve (12) participants completed all activities, data was lost on 2 individuals.

ArmMeasureGroupValue (MEDIAN)
AYA ParticipantsNut ConsumptionBaseline0.30 Number of Servings per week
AYA ParticipantsNut Consumption3 months post-intervention0.30 Number of Servings per week
Primary

Overall Composite of Diet Score

Diet score = (0.03626 × grams/d of cereal fiber + 0.18283 \[if fruits + vegetables ≥3 servings/d\] + 0.14522 \[if nuts 0.1-1 servings/d + 0.2444 \[if nuts \>1 servings/d\]- 0.14631 × servings/d of sugar-sweetened beverages - 0.15624 × servings/d of red and processed meats)\*10 A higher score implies better diet quality. An increase in diet score correlates with a better outcome.

Time frame: Baseline, 3 months months post-enrollment

Population: Includes all participants who completed the baseline questionnaires, and the three-month follow-up includes only those who completed the study activities at the specific time point. Even though twelve (12) participants completed all activities, data was lost on 2 individuals.

ArmMeasureGroupValue (MEDIAN)
AYA ParticipantsOverall Composite of Diet ScoreThree (3) months post-enrollment0.28 Diet Score
AYA ParticipantsOverall Composite of Diet ScoreBaseline0.27 Diet Score
Primary

Physical Activity

Physical activity will be measured in number of hours per week. Increase in physical activity associated with a better outcome.

Time frame: Baseline, 3 months post-enrollment

Population: Includes all participants who completed the baseline questionnaires, and the three-month follow-up includes only those who completed the study activities at the specific time point. Even though twelve (12) participants completed all activities, data was lost on 2 individuals.

ArmMeasureGroupValue (MEDIAN)
AYA ParticipantsPhysical ActivityIntense Physical Activity at Baseline0.75 number of hours per week
AYA ParticipantsPhysical ActivityIntense Physical Activity at 3 months post-enrollment0.75 number of hours per week
AYA ParticipantsPhysical ActivityModerate Physical Activity at Baseline0.75 number of hours per week
AYA ParticipantsPhysical ActivityModerate Physical Activity at 3 months post-enrollment1.38 number of hours per week
Primary

Red and Processed Meats Intake

Intake will be measured with number of servings per day. A decrease in consumption is associated with a better outcome.

Time frame: Baseline, 3 months post-enrollment

Population: Includes all participants who completed the baseline questionnaires, and the three-month follow-up includes only those who completed the study activities at the specific time point. Even though twelve (12) participants completed all activities, data was lost on 2 individuals.

ArmMeasureGroupValue (MEDIAN)
AYA ParticipantsRed and Processed Meats IntakeRed meats at baseline0.30 number of servings per week
AYA ParticipantsRed and Processed Meats IntakeRed meats at 3 months post-enrollment0.30 number of servings per week
AYA ParticipantsRed and Processed Meats IntakeProcessed Meats at Baseline0.50 number of servings per week
AYA ParticipantsRed and Processed Meats IntakeProcessed Meats at 3 months post-enrollment0.30 number of servings per week
Primary

Sugar and Sweetened Beverages

Intake will be measured with number of servings per week. A decrease in consumption is associated with a better outcome.

Time frame: Baseline, 3 months post-enrollment

Population: Includes all participants who completed the baseline questionnaires, and the three-month follow-up includes only those who completed the study activities at the specific time point. Even though twelve (12) participants completed all activities, data was lost on 2 individuals.

ArmMeasureGroupValue (MEDIAN)
AYA ParticipantsSugar and Sweetened BeveragesBaseline0.30 number of servings per week.
AYA ParticipantsSugar and Sweetened BeveragesThree months post-enrollment0.30 number of servings per week.
Secondary

BMI From Baseline

AYA participant's BMI will be measured during the clinic appointment when participant is recruited. AYA participants will then be asked to return for a study visit 3 months post intervention where their BMI will be measured again. Change in BMI will be measured with a decrease in BMI being associated with a positive outcome and an increase in BMI being associated with a negative outcome.

Time frame: Baseline, 3 month post-enrollment

Population: Includes all participants who completed the baseline questionnaires, and the three months follow-up includes only those who completed the study activities at the specific time point.

ArmMeasureGroupValue (MEDIAN)
AYA ParticipantsBMI From BaselineBMI at Baseline24 kg/m^2
AYA ParticipantsBMI From BaselineBMI at 3 months post-enrollment25 kg/m^2
Secondary

Diastolic Blood Pressure (BP) From Baseline

AYA participants' diastolic BP (DBP) will be measured during the clinic appointment when the participant is recruited. AYA participants will then be asked to return for a study visit 3 months post-intervention where their BP will be measured again. Change in DBP will be measured with a decrease in diastolic BP being associated with a positive outcome and an increase in BP being associated with a negative outcome.

Time frame: Baseline, 3 month post-enrollment

Population: Includes all participants who completed the baseline questionnaires, and the three months follow-up includes only those who completed the study activities at the specific time point.

ArmMeasureGroupValue (MEDIAN)
AYA ParticipantsDiastolic Blood Pressure (BP) From BaselineBaseline DBP67 mmHg
AYA ParticipantsDiastolic Blood Pressure (BP) From BaselineDBP at 3 months post-enrollment67 mmHg
Secondary

Systolic Blood Pressure (BP) From Baseline

AYA participants' systolic BP (SBP) will be measured during the clinic appointment when the participant is recruited. AYA participants will then be asked to return for a study visit 3 months post-intervention where their BP will be measured again. Change in SBP will be measured with a decrease in SBP being associated with a positive outcome and an increase in SBP being associated with a negative outcome.

Time frame: Baseline, 3 month post-enrollment

Population: Includes all participants who completed the baseline questionnaires, and the three months follow-up includes only those who completed the study activities at the specific time point.

ArmMeasureGroupValue (MEDIAN)
AYA ParticipantsSystolic Blood Pressure (BP) From BaselineSPB at Baseline118 mmHg
AYA ParticipantsSystolic Blood Pressure (BP) From BaselineSBP at 3 months post-enrollment117 mmHg

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026